Skip to main content

MoneyWorks4Me

Phaarmasia informs about board meeting

07 Nov 2026 Evaluate
Phaarmasia has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 to consider and approve and take on record the un-audited financial results of the company for the quarter and half-year ended 30th September, 2026; To consider and take note of Limited Review Report for the quarter and half-year ended 30th September, 2026; To take note of Compliance Certificate Submitted by Chief Executive Officer and Chief Financial Officer in compliance with SEBI (LODR), 2015; To review and approve the related party transactions, if any; To take note of operations of the Company; To consider, discuss and approve any other matter with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1909.15
Dr. Reddys Labs. 1385.15
Cipla 1422.55
Lupin 1996.50
Zydus Lifesciences 1200.80
View more..